In contrast to the ablation of Trx2 in both WAT and BAT in Trx2ADKO, we observed metabolic benefits after the ablation of TRX2 in BAT, including protection from diet-induced obesity, hypertriglyceridemia, and insulin resistance. This evidence concerns the gene TXN2 and obesity due to melanocortin 4 receptor deficiency.